Document Detail


Sideroblasts and haemosiderin in thyrotoxicosis.
MedLine Citation:
PMID:  7466312     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Bone marrow sideroblasts and haemosiderin were studied in 19 thyrotoxic patients before therapy and in the euthyroid state. The proportion of sideroblasts and the amount of haemosiderin were significantly higher in the hyperthyroid than in the euthyroid phase. Pathological sideroblasts with coarse perinuclear iron granules were found before therapy but not in the euthyroid phase. It is concluded that during thyrotoxicosis the supply of iron into erythroblasts is greater than the amount used for haemoglobin synthesis.
Authors:
R Lahtinen
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Scandinavian journal of haematology     Volume:  25     ISSN:  0036-553X     ISO Abbreviation:  Scand J Haematol     Publication Date:  1980 Sep 
Date Detail:
Created Date:  1981-04-24     Completed Date:  1981-04-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0404507     Medline TA:  Scand J Haematol     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  237-43     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Bone Marrow Examination
Erythroblasts / pathology*
Erythrocyte Volume
Erythrocytes / pathology*
Female
Hemosiderin / analysis*
Humans
Hyperthyroidism / blood,  pathology*
Male
Middle Aged
Chemical
Reg. No./Substance:
9011-92-1/Hemosiderin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Deoxyuridine-suppression test and bone marrow culture for the diagnosis of macrocytic refractory ana...
Next Document:  An association between thalassaemia and autoimmune haemolytic anaemia (AIHA).